BindingDB logo
myBDB logout

null

SMILES: COc1cc(cn2ncnc12)-c1[nH]c2cc(C)c(nc2c1C(C)C)C1CCC(CC1)NC1CCOC1

InChI Key:

Find this compound or compounds like it in BindingDB or PDB:
   Substructure
Similarity at least:  must be >=0.5
Exact match

Activity Spreadsheet -- Enzyme Inhibition Constant Data from BindingDB

Found 12 hits for monomerid = 427894   
Target/Host
(Institution)
LigandTarget/Host
Links
Ligand
Links
Trg + Lig
Links
Ki
nM
ΔG°
kcal/mole
IC50
nM
Kd
nM
EC50/IC50
nM
koff
s-1
kon
M-1s-1
pHTemp
°C
Toll-like receptor 7


(Homo sapiens (Human))
BDBM427894
PNG
(US10544143, Example 328 | US10544143, Example 329 ...)
Show SMILES COc1cc(cn2ncnc12)-c1[nH]c2cc(C)c(nc2c1C(C)C)C1CCC(CC1)NC1CCOC1 |(10.05,1.98,;8.51,1.98,;7.74,.65,;6.2,.65,;5.43,-.69,;6.2,-2.02,;7.74,-2.02,;8.77,-3.16,;10.18,-2.54,;10.02,-1.01,;8.51,-.69,;3.89,-.69,;2.99,-1.93,;1.52,-1.46,;.19,-2.23,;-1.14,-1.46,;-2.48,-2.23,;-1.14,.08,;.19,.85,;1.52,.08,;2.99,.56,;3.39,2.05,;2.3,3.14,;4.87,2.45,;-2.48,.85,;-3.81,.08,;-5.14,.85,;-5.14,2.39,;-3.81,3.16,;-2.48,2.39,;-6.48,3.16,;-7.81,2.39,;-9.28,2.87,;-10.18,1.62,;-9.28,.38,;-7.81,.85,)|
PDB

UniProtKB/SwissProt

antibodypedia
GoogleScholar
AffyNet 
PC cid
PC sid
UniChem
US Patent
n/an/a 0.0800n/an/an/an/an/an/a



Bristol-Myers Squibb Company

US Patent


Assay Description
HEK-Blue-cells (Invivogen) overexpressing human TLR7, TLR8 or TLR9 receptors were used for screening inhibitors of these receptors using an inducible...


US Patent US10544143 (2020)


BindingDB Entry DOI: 10.7270/Q2QF8W80
More data for this
Ligand-Target Pair
Toll-like receptor 8


(Homo sapiens (Human))
BDBM427894
PNG
(US10544143, Example 328 | US10544143, Example 329 ...)
Show SMILES COc1cc(cn2ncnc12)-c1[nH]c2cc(C)c(nc2c1C(C)C)C1CCC(CC1)NC1CCOC1 |(10.05,1.98,;8.51,1.98,;7.74,.65,;6.2,.65,;5.43,-.69,;6.2,-2.02,;7.74,-2.02,;8.77,-3.16,;10.18,-2.54,;10.02,-1.01,;8.51,-.69,;3.89,-.69,;2.99,-1.93,;1.52,-1.46,;.19,-2.23,;-1.14,-1.46,;-2.48,-2.23,;-1.14,.08,;.19,.85,;1.52,.08,;2.99,.56,;3.39,2.05,;2.3,3.14,;4.87,2.45,;-2.48,.85,;-3.81,.08,;-5.14,.85,;-5.14,2.39,;-3.81,3.16,;-2.48,2.39,;-6.48,3.16,;-7.81,2.39,;-9.28,2.87,;-10.18,1.62,;-9.28,.38,;-7.81,.85,)|
PDB

UniProtKB/SwissProt

antibodypedia
GoogleScholar
AffyNet 
PC cid
PC sid
UniChem
US Patent
n/an/a 1.10n/an/an/an/an/an/a



Bristol-Myers Squibb Company

US Patent


Assay Description
HEK-Blue-cells (Invivogen) overexpressing human TLR7, TLR8 or TLR9 receptors were used for screening inhibitors of these receptors using an inducible...


US Patent US10544143 (2020)


BindingDB Entry DOI: 10.7270/Q2QF8W80
More data for this
Ligand-Target Pair
Toll-like receptor 9


(Homo sapiens (Human))
BDBM427894
PNG
(US10544143, Example 328 | US10544143, Example 329 ...)
Show SMILES COc1cc(cn2ncnc12)-c1[nH]c2cc(C)c(nc2c1C(C)C)C1CCC(CC1)NC1CCOC1 |(10.05,1.98,;8.51,1.98,;7.74,.65,;6.2,.65,;5.43,-.69,;6.2,-2.02,;7.74,-2.02,;8.77,-3.16,;10.18,-2.54,;10.02,-1.01,;8.51,-.69,;3.89,-.69,;2.99,-1.93,;1.52,-1.46,;.19,-2.23,;-1.14,-1.46,;-2.48,-2.23,;-1.14,.08,;.19,.85,;1.52,.08,;2.99,.56,;3.39,2.05,;2.3,3.14,;4.87,2.45,;-2.48,.85,;-3.81,.08,;-5.14,.85,;-5.14,2.39,;-3.81,3.16,;-2.48,2.39,;-6.48,3.16,;-7.81,2.39,;-9.28,2.87,;-10.18,1.62,;-9.28,.38,;-7.81,.85,)|
UniProtKB/SwissProt

antibodypedia
GoogleScholar
AffyNet 
PC cid
PC sid
UniChem
US Patent
n/an/a 576n/an/an/an/an/an/a



Bristol-Myers Squibb Company

US Patent


Assay Description
HEK-Blue-cells (Invivogen) overexpressing human TLR7, TLR8 or TLR9 receptors were used for screening inhibitors of these receptors using an inducible...


US Patent US10544143 (2020)


BindingDB Entry DOI: 10.7270/Q2QF8W80
More data for this
Ligand-Target Pair
Toll-like receptor 7


(Homo sapiens (Human))
BDBM427894
PNG
(US10544143, Example 328 | US10544143, Example 329 ...)
Show SMILES COc1cc(cn2ncnc12)-c1[nH]c2cc(C)c(nc2c1C(C)C)C1CCC(CC1)NC1CCOC1 |(10.05,1.98,;8.51,1.98,;7.74,.65,;6.2,.65,;5.43,-.69,;6.2,-2.02,;7.74,-2.02,;8.77,-3.16,;10.18,-2.54,;10.02,-1.01,;8.51,-.69,;3.89,-.69,;2.99,-1.93,;1.52,-1.46,;.19,-2.23,;-1.14,-1.46,;-2.48,-2.23,;-1.14,.08,;.19,.85,;1.52,.08,;2.99,.56,;3.39,2.05,;2.3,3.14,;4.87,2.45,;-2.48,.85,;-3.81,.08,;-5.14,.85,;-5.14,2.39,;-3.81,3.16,;-2.48,2.39,;-6.48,3.16,;-7.81,2.39,;-9.28,2.87,;-10.18,1.62,;-9.28,.38,;-7.81,.85,)|
PDB

UniProtKB/SwissProt

antibodypedia
GoogleScholar
AffyNet 
PC cid
PC sid
UniChem
US Patent
n/an/a 1.60n/an/an/an/an/an/a



Bristol-Myers Squibb Company

US Patent


Assay Description
HEK-Blue-cells (Invivogen) overexpressing human TLR7, TLR8 or TLR9 receptors were used for screening inhibitors of these receptors using an inducible...


US Patent US10544143 (2020)


BindingDB Entry DOI: 10.7270/Q2QF8W80
More data for this
Ligand-Target Pair
Toll-like receptor 8


(Homo sapiens (Human))
BDBM427894
PNG
(US10544143, Example 328 | US10544143, Example 329 ...)
Show SMILES COc1cc(cn2ncnc12)-c1[nH]c2cc(C)c(nc2c1C(C)C)C1CCC(CC1)NC1CCOC1 |(10.05,1.98,;8.51,1.98,;7.74,.65,;6.2,.65,;5.43,-.69,;6.2,-2.02,;7.74,-2.02,;8.77,-3.16,;10.18,-2.54,;10.02,-1.01,;8.51,-.69,;3.89,-.69,;2.99,-1.93,;1.52,-1.46,;.19,-2.23,;-1.14,-1.46,;-2.48,-2.23,;-1.14,.08,;.19,.85,;1.52,.08,;2.99,.56,;3.39,2.05,;2.3,3.14,;4.87,2.45,;-2.48,.85,;-3.81,.08,;-5.14,.85,;-5.14,2.39,;-3.81,3.16,;-2.48,2.39,;-6.48,3.16,;-7.81,2.39,;-9.28,2.87,;-10.18,1.62,;-9.28,.38,;-7.81,.85,)|
PDB

UniProtKB/SwissProt

antibodypedia
GoogleScholar
AffyNet 
PC cid
PC sid
UniChem
US Patent
n/an/a 23n/an/an/an/an/an/a



Bristol-Myers Squibb Company

US Patent


Assay Description
HEK-Blue-cells (Invivogen) overexpressing human TLR7, TLR8 or TLR9 receptors were used for screening inhibitors of these receptors using an inducible...


US Patent US10544143 (2020)


BindingDB Entry DOI: 10.7270/Q2QF8W80
More data for this
Ligand-Target Pair
Toll-like receptor 9


(Homo sapiens (Human))
BDBM427894
PNG
(US10544143, Example 328 | US10544143, Example 329 ...)
Show SMILES COc1cc(cn2ncnc12)-c1[nH]c2cc(C)c(nc2c1C(C)C)C1CCC(CC1)NC1CCOC1 |(10.05,1.98,;8.51,1.98,;7.74,.65,;6.2,.65,;5.43,-.69,;6.2,-2.02,;7.74,-2.02,;8.77,-3.16,;10.18,-2.54,;10.02,-1.01,;8.51,-.69,;3.89,-.69,;2.99,-1.93,;1.52,-1.46,;.19,-2.23,;-1.14,-1.46,;-2.48,-2.23,;-1.14,.08,;.19,.85,;1.52,.08,;2.99,.56,;3.39,2.05,;2.3,3.14,;4.87,2.45,;-2.48,.85,;-3.81,.08,;-5.14,.85,;-5.14,2.39,;-3.81,3.16,;-2.48,2.39,;-6.48,3.16,;-7.81,2.39,;-9.28,2.87,;-10.18,1.62,;-9.28,.38,;-7.81,.85,)|
UniProtKB/SwissProt

antibodypedia
GoogleScholar
AffyNet 
PC cid
PC sid
UniChem
US Patent
n/an/a 2.07E+3n/an/an/an/an/an/a



Bristol-Myers Squibb Company

US Patent


Assay Description
HEK-Blue-cells (Invivogen) overexpressing human TLR7, TLR8 or TLR9 receptors were used for screening inhibitors of these receptors using an inducible...


US Patent US10730877 (2020)

More data for this
Ligand-Target Pair
Toll-like receptor 7


(Homo sapiens (Human))
BDBM427894
PNG
(US10544143, Example 328 | US10544143, Example 329 ...)
Show SMILES COc1cc(cn2ncnc12)-c1[nH]c2cc(C)c(nc2c1C(C)C)C1CCC(CC1)NC1CCOC1 |(10.05,1.98,;8.51,1.98,;7.74,.65,;6.2,.65,;5.43,-.69,;6.2,-2.02,;7.74,-2.02,;8.77,-3.16,;10.18,-2.54,;10.02,-1.01,;8.51,-.69,;3.89,-.69,;2.99,-1.93,;1.52,-1.46,;.19,-2.23,;-1.14,-1.46,;-2.48,-2.23,;-1.14,.08,;.19,.85,;1.52,.08,;2.99,.56,;3.39,2.05,;2.3,3.14,;4.87,2.45,;-2.48,.85,;-3.81,.08,;-5.14,.85,;-5.14,2.39,;-3.81,3.16,;-2.48,2.39,;-6.48,3.16,;-7.81,2.39,;-9.28,2.87,;-10.18,1.62,;-9.28,.38,;-7.81,.85,)|
PDB

UniProtKB/SwissProt

antibodypedia
GoogleScholar
AffyNet 
PC cid
PC sid
UniChem
US Patent
n/an/a 0.0800n/an/an/an/an/an/a



Bristol-Myers Squibb Company

US Patent


Assay Description
HEK-Blue-cells (Invivogen) overexpressing human TLR7, TLR8 or TLR9 receptors were used for screening inhibitors of these receptors using an inducible...


US Patent US10730877 (2020)

More data for this
Ligand-Target Pair
Toll-like receptor 8


(Homo sapiens (Human))
BDBM427894
PNG
(US10544143, Example 328 | US10544143, Example 329 ...)
Show SMILES COc1cc(cn2ncnc12)-c1[nH]c2cc(C)c(nc2c1C(C)C)C1CCC(CC1)NC1CCOC1 |(10.05,1.98,;8.51,1.98,;7.74,.65,;6.2,.65,;5.43,-.69,;6.2,-2.02,;7.74,-2.02,;8.77,-3.16,;10.18,-2.54,;10.02,-1.01,;8.51,-.69,;3.89,-.69,;2.99,-1.93,;1.52,-1.46,;.19,-2.23,;-1.14,-1.46,;-2.48,-2.23,;-1.14,.08,;.19,.85,;1.52,.08,;2.99,.56,;3.39,2.05,;2.3,3.14,;4.87,2.45,;-2.48,.85,;-3.81,.08,;-5.14,.85,;-5.14,2.39,;-3.81,3.16,;-2.48,2.39,;-6.48,3.16,;-7.81,2.39,;-9.28,2.87,;-10.18,1.62,;-9.28,.38,;-7.81,.85,)|
PDB

UniProtKB/SwissProt

antibodypedia
GoogleScholar
AffyNet 
PC cid
PC sid
UniChem
US Patent
n/an/a 1.10n/an/an/an/an/an/a



Bristol-Myers Squibb Company

US Patent


Assay Description
HEK-Blue-cells (Invivogen) overexpressing human TLR7, TLR8 or TLR9 receptors were used for screening inhibitors of these receptors using an inducible...


US Patent US10730877 (2020)

More data for this
Ligand-Target Pair
Toll-like receptor 9


(Homo sapiens (Human))
BDBM427894
PNG
(US10544143, Example 328 | US10544143, Example 329 ...)
Show SMILES COc1cc(cn2ncnc12)-c1[nH]c2cc(C)c(nc2c1C(C)C)C1CCC(CC1)NC1CCOC1 |(10.05,1.98,;8.51,1.98,;7.74,.65,;6.2,.65,;5.43,-.69,;6.2,-2.02,;7.74,-2.02,;8.77,-3.16,;10.18,-2.54,;10.02,-1.01,;8.51,-.69,;3.89,-.69,;2.99,-1.93,;1.52,-1.46,;.19,-2.23,;-1.14,-1.46,;-2.48,-2.23,;-1.14,.08,;.19,.85,;1.52,.08,;2.99,.56,;3.39,2.05,;2.3,3.14,;4.87,2.45,;-2.48,.85,;-3.81,.08,;-5.14,.85,;-5.14,2.39,;-3.81,3.16,;-2.48,2.39,;-6.48,3.16,;-7.81,2.39,;-9.28,2.87,;-10.18,1.62,;-9.28,.38,;-7.81,.85,)|
UniProtKB/SwissProt

antibodypedia
GoogleScholar
AffyNet 
PC cid
PC sid
UniChem
US Patent
n/an/a 576n/an/an/an/an/an/a



Bristol-Myers Squibb Company

US Patent


Assay Description
HEK-Blue-cells (Invivogen) overexpressing human TLR7, TLR8 or TLR9 receptors were used for screening inhibitors of these receptors using an inducible...


US Patent US10730877 (2020)

More data for this
Ligand-Target Pair
Toll-like receptor 7


(Homo sapiens (Human))
BDBM427894
PNG
(US10544143, Example 328 | US10544143, Example 329 ...)
Show SMILES COc1cc(cn2ncnc12)-c1[nH]c2cc(C)c(nc2c1C(C)C)C1CCC(CC1)NC1CCOC1 |(10.05,1.98,;8.51,1.98,;7.74,.65,;6.2,.65,;5.43,-.69,;6.2,-2.02,;7.74,-2.02,;8.77,-3.16,;10.18,-2.54,;10.02,-1.01,;8.51,-.69,;3.89,-.69,;2.99,-1.93,;1.52,-1.46,;.19,-2.23,;-1.14,-1.46,;-2.48,-2.23,;-1.14,.08,;.19,.85,;1.52,.08,;2.99,.56,;3.39,2.05,;2.3,3.14,;4.87,2.45,;-2.48,.85,;-3.81,.08,;-5.14,.85,;-5.14,2.39,;-3.81,3.16,;-2.48,2.39,;-6.48,3.16,;-7.81,2.39,;-9.28,2.87,;-10.18,1.62,;-9.28,.38,;-7.81,.85,)|
PDB

UniProtKB/SwissProt

antibodypedia
GoogleScholar
AffyNet 
PC cid
PC sid
UniChem
US Patent
n/an/a 1.60n/an/an/an/an/an/a



Bristol-Myers Squibb Company

US Patent


Assay Description
HEK-Blue-cells (Invivogen) overexpressing human TLR7, TLR8 or TLR9 receptors were used for screening inhibitors of these receptors using an inducible...


US Patent US10730877 (2020)

More data for this
Ligand-Target Pair
Toll-like receptor 8


(Homo sapiens (Human))
BDBM427894
PNG
(US10544143, Example 328 | US10544143, Example 329 ...)
Show SMILES COc1cc(cn2ncnc12)-c1[nH]c2cc(C)c(nc2c1C(C)C)C1CCC(CC1)NC1CCOC1 |(10.05,1.98,;8.51,1.98,;7.74,.65,;6.2,.65,;5.43,-.69,;6.2,-2.02,;7.74,-2.02,;8.77,-3.16,;10.18,-2.54,;10.02,-1.01,;8.51,-.69,;3.89,-.69,;2.99,-1.93,;1.52,-1.46,;.19,-2.23,;-1.14,-1.46,;-2.48,-2.23,;-1.14,.08,;.19,.85,;1.52,.08,;2.99,.56,;3.39,2.05,;2.3,3.14,;4.87,2.45,;-2.48,.85,;-3.81,.08,;-5.14,.85,;-5.14,2.39,;-3.81,3.16,;-2.48,2.39,;-6.48,3.16,;-7.81,2.39,;-9.28,2.87,;-10.18,1.62,;-9.28,.38,;-7.81,.85,)|
PDB

UniProtKB/SwissProt

antibodypedia
GoogleScholar
AffyNet 
PC cid
PC sid
UniChem
US Patent
n/an/a 23n/an/an/an/an/an/a



Bristol-Myers Squibb Company

US Patent


Assay Description
HEK-Blue-cells (Invivogen) overexpressing human TLR7, TLR8 or TLR9 receptors were used for screening inhibitors of these receptors using an inducible...


US Patent US10730877 (2020)

More data for this
Ligand-Target Pair
Toll-like receptor 9


(Homo sapiens (Human))
BDBM427894
PNG
(US10544143, Example 328 | US10544143, Example 329 ...)
Show SMILES COc1cc(cn2ncnc12)-c1[nH]c2cc(C)c(nc2c1C(C)C)C1CCC(CC1)NC1CCOC1 |(10.05,1.98,;8.51,1.98,;7.74,.65,;6.2,.65,;5.43,-.69,;6.2,-2.02,;7.74,-2.02,;8.77,-3.16,;10.18,-2.54,;10.02,-1.01,;8.51,-.69,;3.89,-.69,;2.99,-1.93,;1.52,-1.46,;.19,-2.23,;-1.14,-1.46,;-2.48,-2.23,;-1.14,.08,;.19,.85,;1.52,.08,;2.99,.56,;3.39,2.05,;2.3,3.14,;4.87,2.45,;-2.48,.85,;-3.81,.08,;-5.14,.85,;-5.14,2.39,;-3.81,3.16,;-2.48,2.39,;-6.48,3.16,;-7.81,2.39,;-9.28,2.87,;-10.18,1.62,;-9.28,.38,;-7.81,.85,)|
UniProtKB/SwissProt

antibodypedia
GoogleScholar
AffyNet 
PC cid
PC sid
UniChem
US Patent
n/an/a 2.07E+3n/an/an/an/an/an/a



Bristol-Myers Squibb Company

US Patent


Assay Description
HEK-Blue-cells (Invivogen) overexpressing human TLR7, TLR8 or TLR9 receptors were used for screening inhibitors of these receptors using an inducible...


US Patent US10544143 (2020)


BindingDB Entry DOI: 10.7270/Q2QF8W80
More data for this
Ligand-Target Pair